HYPOTHESISMaintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia
References (37)
- et al.
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG 106 by the Children's Cancer Study Group
Lancet
(1988) - et al.
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
Lancet
(1991) - et al.
Studies of sequential and combination antimetabolite therapy in acute leukemia: 6 mercaptopurine and methotrexate
Blood
(1961) Therapy of acute lymphoblastic leukemia in childhood
Blood
(1980)- et al.
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lancet
(1990) - et al.
Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis
Blood
(1990) - et al.
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia
Lancet
(1991) - et al.
Spontaneous natural killer cell activity in childhood acute lymphoblastic leukaemia
Eur J Cancer Clin Oncol
(1987) - et al.
Prolonged defects of interleukin-2 production responsiveness and receptor expression in patients with acute lymphoblastic leukemia
Blood
(1989) - et al.
Graft-versus-leukemia reactions after bone marrow transplantations
Blood
(1990)
To B or not to B: that is the question
Immunol Today
(1991)
Plasma cell myeloma: new biological insight and advances in therapy
Blood
(1989)
Four agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia
N Engl J Med
(1986)
Therapy results of five ALL-BFM studies since 1970. Implications of risk factors for prognosis
Curr Stud Hematol Blood Transfus
(1987)
Curing children of leukemia
Cancer
(1987)
The genetic origin of drug resistance in neoplasm: implications for systemic therapy
Cancer Res
(1984)
Drug dosage and remission duration in childhood lymphocytic leukemia
Cancer
(1971)
Cited by (50)
Validation and application of a high-performance liquid chromatographic-based assay for determination of the inosine 5′-monophosphate dehydrogenase activity in erythrocytes
2006, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesThe clinical significance of detection of residual disease in childhood ALL
1998, Critical Reviews in Oncology/HematologyMeasurable residual disease in childhood B-cell acute lymphoblastic leukemia
2022, Blood Science
Copyright © 1991 Published by Elsevier Ltd.